2013
DOI: 10.1016/j.jcm.2013.01.001
|View full text |Cite
|
Sign up to set email alerts
|

Botulinum toxin type A combined with neurodynamic mobilization for lower limb spasticity: a case report

Abstract: Objective: This case report describes a patient with severe lower limb spasticity treated with botulinum toxin type A (BoNT-A) and neurodynamic mobilization (NM). Clinical Features: An 81-year-old male patient presented with a severe spastic lower limbs after total right hip replacement and severe alcoholic polyneuropathy. After the right hip replacement, he presented with generalized spasticity, crouched posture, and a large sacral pressure sore. The severe spasticity in his knees prevented walking. Intervent… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
9
0

Year Published

2013
2013
2022
2022

Publication Types

Select...
7

Relationship

1
6

Authors

Journals

citations
Cited by 10 publications
(9 citation statements)
references
References 36 publications
0
9
0
Order By: Relevance
“…These findings can be explained as follows. If tension is applied to the nervous system while applying neurodynamics, the reduction of the cross-sectional area and increase in pressure in the nerve result in extension and movement of the sciatic nerve together with the hamstring and compliance of the nerve, resulting in increased flexibility [26,27].…”
Section: Discussionmentioning
confidence: 99%
“…These findings can be explained as follows. If tension is applied to the nervous system while applying neurodynamics, the reduction of the cross-sectional area and increase in pressure in the nerve result in extension and movement of the sciatic nerve together with the hamstring and compliance of the nerve, resulting in increased flexibility [26,27].…”
Section: Discussionmentioning
confidence: 99%
“…11,[21][22][23] According to Nee and Butler (2006), cited in Boyd et al, 24 the criteria for interpretation of neurodynamic testing include whether the test (a) reproduces the symptoms, (b) identifies a significant deviation from normal, or (c) produces alterations in the symptoms by adding in a distal joint movement, also called sensitizing movements. 24 For example, muscle EMG activity, location of symptoms, and hip motions are altered when performing 2 sensitizing versions of the straight leg raise maneuver, assisting clinicians to Fig 3. A, Proximal slider, a straight leg raise and application of plantar-flexion without producing symptoms.…”
Section: Discussionmentioning
confidence: 99%
“…Each patient underwent both subjective and physical examination performed by a physician experienced in neurologic conditions and rehabilitation to evaluate the patients in regard to the inclusion and exclusion criteria. To be included in the study, the patients needed to have a history of acute phase of stroke, 41 first stroke episode, no history of peripheral nerve injury or musculoskeletal disease (eg, arthritis, musculotendinous injury, or bone fracture) in the affected upper extremity, no contracture of the affected wrist or fingers (Modified Ashworth < 3), 6 and no history of any invasive procedure (Botulinum toxin type A) for the treatment of spasticity for at least 6 months prior to the start of this study, 17,36 and paralysis of the wrist and fingers and absence in voluntarily initiating and controlling finger extension movements. The exclusion criteria included unstable medical disorders, active complex regional pain syndrome, severe spatial neglect, aphasia, or cognitive problems.…”
Section: Methodsmentioning
confidence: 99%